In this study, we discovered that the expression of the LPC transporter Mfsd2a in the liver is under the control of GR action to respond to dietary fat feeding, where it plays an essential role in protecting the liver from NAFLD in the presence of HFD challenge. This evidence concerns the gene NR3C1 and metabolic dysfunction-associated steatotic liver disease.